metricas
covid
Medicina Clínica (English Edition) Effectiveness of alirocumab and evolocumab (PCSK9i) for the treatment of hyperch...
Journal Information

Statistics

Follow this link to access the full text of the article

Letter to the Editor
Effectiveness of alirocumab and evolocumab (PCSK9i) for the treatment of hypercholesterolemia
Efectividad de alirocumab y evolocumab (PCSK9i) en el tratamiento de la hipercolesterolemia
Francisco José Fernández-Fernándeza,
Corresponding author
fjf.fernandez2@gmail.com

Corresponding author.
, Eugenia Ameneiros-Lagoa, Alberto Muñiz-Gutiérrezb
a Unidad de Lípidos y Riesgo Vascular, Servicio de Medicina Interna, Complejo Hospitalario Universitario de Ferrol, Ferrol (La Coruña), Spain
b Servicio de Medicina Interna, Complejo Hospitalario Universitario de Ferrol, Ferrol (La Coruña), Spain
Read
38
Times
was read the article
0
Total PDF
38
Total HTML
Share statistics
Article information
ISSN: 23870206
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 38 0 38

Follow this link to access the full text of the article

Article options
Tools